BANGALORE, India | 13th November 2020: A new Autoinjectors Market Research Report published on Valuates Reports in Medical Devices & Equipments Category. The report contains segmentation by Type (Disposable Autoinjectors and Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), and End user (Homecare Settings and Hospitals & Clinics). It also covers Global Opportunity Analysis and Industry Forecast to 2027.

The Global Autoinjectors Market size was valued at USD 1,509.0 Million in 2019 and is expected to reach USD  5,732.6 Million by 2027, with a CAGR of 18.1% during the forecast period.

Major factors driving the autoinjector market size are the growing prevalence of targeted therapies, the increasing incidence of anaphylaxis, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government funding.

The study provides an in-depth analysis of the global autoinjectors market size along with the current trends and future estimations to elucidate the imminent investment pockets.

Inquire For Sample:


The favorable reimbursement environment and government support encouraging the use of autoinjectors drive the growth of autoinjector market size.

Autoinjectors offer many advantages, such as reducing needle-related phobias of anxiety, reducing the chances of needle-stick accidents, preserving dosage accuracy consistency, and improving effectiveness. Thus, the autoinjectors market size is expected to grow during the forecast period due to such advantages.

The patent expiry of biologics, novel formulations and revolutionary drug delivery methods, coupled with the discovery and improvement of bio-drugs, the rise in healthcare spending, the increase in anaphylaxis and the accessibility of generic autoinjector varieties also promote the growth of autoinjectors market size.

The injection site of a drug is selected on the nature of the drug but is typically administered intramuscularly. Autoinjectors are less painful than syringes, which in turn increase the growth of autoinjectors market size.

View Full Report:


Based on the Application,  the anaphylaxis segment held the largest autoinjectors market share ( about 38.5% )during the forecast period.

Based on end-user, the home care settings segment held the largest autoinjectors market share, accounting for about 62.8% share in 2019.

Based on type, the disposable autoinjectors segment dominated the largest autoinjectors market share in 2019 and is expected to continue this trend throughout the forecast period. Key factors such as increased incidence of anaphylaxis and rheumatoid arthritis and increased patient demand for autoinjectors drive this segment’s growth.

North America accounted for the largest autoinjectors market share. This is due to advances in medical equipment technology, modern healthcare facilities and high demand for quality goods.

Asia-Pacific is predicted to experience the highest growth rate during the projected period. Growing cases of anaphylaxis, rheumatoid arthritis, and other diseases such as anemia and migraine; and further technological advances by companies are expected to drive overall market growth.

 Inquire For Regional Report:


By Type

  • Disposable autoinjectors
  • Reusable autoinjectors

By Application

  • Rheumatoid Arthritis
  • Anaphylaxis
  • Multiple Sclerosis
  • Others

By End user

  • Home care settings
  • Hospitals & Clinics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Buy Now for Single User + COVID-19 Impacts:

Buy Now for Enterprise User + COVID-19 Impacts:


We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.


  • The global demand for Disposable Autoinjectors Market size is driven by an increase in the prevalence of diabetes, rheumatoid arthritis, multiple sclerosis and other diseases. The report includes a country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
  • Japan Autoinjectors Market report studies the Autoinjectors development status and future trend in Japan, focuses on top players in Japan, also splits Autoinjectors by type and by Application, to fully and deeply research and reveal the market situation and future forecast.
  • The global Epinephrine Autoinjectors Market size is projected to reach USD 3031.2 Million by 2026, from USD 1877.8 Million in 2019, at a CAGR of 7.0% during 2021-2026. North America held the largest Epinephrine Autoinjectors Sales Market share. In 2015, the North American Epinephrine Autoinjectors market held 93% in the production market and 60% percent in the consumption volume market.The report segmented by Type – 0.30 mg,  0.15 mg, by Application – Under 6 years, 6 to 12 year,  Over 12 years, by key players – Mylan, Sanofi, ALK Abello, Impax & Regions.
  • Automated Autoinjectors Market report segmented by type – Reusable Autoinjectors, Disposable Autoinjectors, by application –  home care setting, hospitals & clinics, by various regions & key players.
  • Customized Autoinjector Market report segmented by type – Reusable Autoinjectors, Disposable Autoinjectors, by application –  home care setting, hospitals & clinics, by various regions & key players.
  • Sumatriptan Autoinjector Market report segmented by type – 4mg, 6mg, by application –  home care setting, hospitals & clinics, by various regions & key players.

Click Here to Find Similar Reports on Autoinjectors Market